Over $14M Bet On Diversified Healthcare Trust? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed higher by over 40 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Diversified Healthcare Trust

• The Trade: Diversified Healthcare Trust DHC Director Adam D Portnoy acquired a total 5,995,200 shares an average price of $2.45. To acquire these shares, it cost around $14.72 million.
• What’s Happening: Diversified Healthcare posted better-than-expected quarterly sales.
• What Diversified Healthcare Trust Does: Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities.

Star Equity Holdings

• The Trade: Star Equity Holdings, Inc. STRR Executive Chairman Jeffrey E Eberwein acquired a total of 102,000 shares at an average price of $1.09. The insider spent around $111.46 thousand to buy those shares.
• What’s Happening: Star Equity posted a profit for the first quarter.
• What Star Equity Holdings Does: Star Equity Holdings Inc is a multi-industry diversified holding company with three segments; Healthcare segment provides products and services in the area of nuclear medicine imaging with a focus on cardiac health.

Adverum Biotechnologies

• The Trade: Adverum Biotechnologies, Inc. ADVM CFO Linda Rubinstein acquired a total of 100,000 shares at an average price of $1.45. To acquire these shares, it cost around $145.49 thousand.
• What’s Happening: Adverum Biotechnologies introduced an intravitreal gene therapy program for geographic atrophy and presented data on its ocular gene therapy platform.
• What Adverum Biotechnologies Does: Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein.

Check This Out: Traders More Optimistic After Dow Records Gains For Third Consecutive Session

Don’t forget to check out our premarket coverage here